.Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX01_Iobenguane123i.Iobenguane123i .Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX01_Iobenguane123i.Iobenguane123i| name: | Iobenguane123i | |
| ATC code: | V09IX01 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 370 | mg |
| volume of distribution: | 4.5 | L |
| clearance: | 0.17 | L/h/kg |
| other parameters in model implementation | ||
Iobenguane (123I), also known as 123I-metaiodobenzylguanidine or 123I-MIBG, is a radiopharmaceutical used for diagnostic imaging of neuroendocrine tumors such as pheochromocytoma and neuroblastoma. It is labeled with radioactive iodine-123, and is currently approved and used in nuclear medicine imaging.
Pharmacokinetic parameters reported in adult patients undergoing diagnostic imaging for neuroendocrine tumors.